omagyvoham.wordpress.com
million, or a total enterprise value ofabout $155 million, including net indebtedness. Monogramj is a provider of molecular diagnostic product that help guide and targetappropriate treatments. The company’s proprietaryt Trofile product identifies patients who are eligibler for a class of HIV drugs and is the widelyt adopted companion diagnostic for the HIV drug Other Monogram productsidentify patients’ resistance to viral helping doctors design individual treatments. “The transaction announced today is a significant step in the executiobof LabCorp’s strategy of leadership in personalized said David P. King, chairman and CEO of LabCorp.
“By utilizinv LabCorp’s national infrastructure to builxdon Monogram’s already strong sales, we will advanc e our leadership in infectious disease and cancere testing, companion diagnostics and personalizede medicine. We look forward to providing improved offerings to both ourand Monogram’ds current customers.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment